Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease

Inclusion Criteria

• •Must have TFBUT of ≤ 5 seconds in at least one eye at Screening visit.
• •Must have best corrected visual acuity (BCVA) of ≥ 20/80 (or ≥ 55 letters score or ≥ 0.6 early treatment diabetic retinopathy study (ETDRS) log of the minimum angle of resolution (LogMAR) value) in both eyes at the Screening visit.
• •Must be willing to discontinue use of all artificial tear supplements and use only the study product as directed for the entire study duration.